Scandinavian ChemoTech's subsidiary Vetiqure signs agreement with Evidensia Specialistdjursjukhuset Helsingborg
Today, Vetiqure signed a collaboration agreement that gives the veterinary hospital access to a vetIQure™ in order to start treatments of animals suffering from cancer. Initially, smaller animals, such as dogs and cats, will be treated.
Vetiqure continues to, through intensive marketing during the spring and summer, create attention and interest among veterinarians in both Europe and the United States. It is beginning to become clear that many veterinarians with previous experience in electrochemotherapy see vetIQure's unique and dynamic TSE technology as very interesting and significant.
"We are very pleased to be able to start TSE treatments at Evidensia Specialistdjursjukhuset Helsingborg and look forward to a successful collaboration in order to reduce suffering for many animals, while providing commercial success for both parties" - says Anders Johnsson, business area manager for Vetiqure AB
For more information regarding Evidensia Specialistdjursjukhuset Helsingborg (in Swedish):
https://evidensia.se/klinik/evidensia-specialistdjursjukhuset-helsingborg/
